How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,365 results for

Medication Causes of Dyspepsia

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Fibrositis of Rectus Abdominis Muscles causing Dyspepsia Full Text available with Trip Pro

Fibrositis of Rectus Abdominis Muscles causing Dyspepsia 20785552 2011 04 04 2011 04 04 0007-1447 2 4359 1944 Jul 22 British medical journal Br Med J Fibrositis of Rectus Abdominis Muscles causing Dyspepsia. 114 Harvey R S RS eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1944 7 22 0 0 1944 7 22 0 1 ppublish 20785552 PMC2285856

1944 British medical journal

62. Gallstones and flatulent dyspepsia: cause or coincidence? Full Text available with Trip Pro

Gallstones and flatulent dyspepsia: cause or coincidence? 5138744 1972 04 06 2018 11 13 0032-5473 47 554 1971 Dec Postgraduate medical journal Postgrad Med J Gallstones and flatulent dyspepsia: cause or coincidence? 767-72 Johnson A G AG eng Journal Article England Postgrad Med J 0234135 0032-5473 0 Dietary Fats IM Cholecystography Cholelithiasis complications Dietary Fats Dyspepsia complications Female Flatulence complications Humans Male Middle Aged 1971 12 1 1971 12 1 0 1 1971 12 1 0 0

1971 Postgraduate medical journal

63. Thread sutures seen on gastroscopy: do they cause ulcers or indigestion? Full Text available with Trip Pro

Thread sutures seen on gastroscopy: do they cause ulcers or indigestion? 922405 1978 01 27 2018 11 13 0007-1447 2 6093 1977 Oct 15 British medical journal Br Med J Thread sutures seen on gastroscopy: do they cause ulcers or indigestion? 996-7 Hoare A M AM Alexander-Williams J J eng Journal Article England Br Med J 0372673 0007-1447 AIM IM Humans Peptic Ulcer etiology Postoperative Complications Recurrence Sutures 1977 10 15 1977 10 15 0 1 1977 10 15 0 0 ppublish 922405 PMC1631776 Br J Surg

1977 British medical journal

64. A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease Full Text available with Trip Pro

A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease 20749190 2011 03 29 2011 03 29 0007-1447 1 957 1879 May 03 British medical journal Br Med J A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease. 660-1 Leared A A eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1879 5 3 0 0 1879 5 3 0 1 ppublish 20749190 PMC2240286

1879 British medical journal

65. A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease Full Text available with Trip Pro

A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease 20749184 2011 03 29 2011 03 29 0007-1447 1 956 1879 Apr 26 British medical journal Br Med J A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease. 622-3 Leared A A eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1879 4 26 0 0 1879 4 26 0 1 ppublish 20749184 PMC2240030

1879 British medical journal

66. THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA Full Text available with Trip Pro

THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA 20764921 2011 03 29 2011 03 29 0007-1447 1 2563 1910 Feb 12 British medical journal Br Med J THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA. 371-5 Fenwick W S WS eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1910 2 12 0 0 1910 2 12 0 1 ppublish 20764921 PMC2330345

1910 British medical journal

67. Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA Full Text available with Trip Pro

Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA 20764965 2011 03 29 2011 03 29 0007-1447 1 2567 1910 Mar 12 British medical journal Br Med J Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA. 613-6 Drummond D D eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1910 3 12 0 0 1910 3 12 0 1 ppublish 20764965 PMC2330717

1910 British medical journal

68. Comparison of intravenous pantoprazole and ranitidine in patients with dyspepsia presented to the emergency department: a randomized, double blind, controlled trial. Full Text available with Trip Pro

in a 100 mL saline solution by an intravenous rapid infusion within 2-4 minutes in patients with dyspepsia presented to the ED. Pain intensity was measured at baseline, 30 and 60 minutes after the drug administration.A total of 72 patients were eligible for the study. Of these patients, 2 were excluded from the study because the initial visual analogue scale (VAS) scores were under 20 mm and 4 were excluded from the statistical analysis because of being diagnosed as having other causes of epigastric (...) Comparison of intravenous pantoprazole and ranitidine in patients with dyspepsia presented to the emergency department: a randomized, double blind, controlled trial. This study aimed to compare pantoprazole, a proton-pomp inhibitors (PPIs), and ranitidine, a H2 receptor antagonists (H2RA), in ceasing dyspeptic symptoms in the emergency department (ED).This randomized, double-blinded study compared the effectiveness of 50 mg ranitidine (Ulcuran(®)) and 40 mg pantoprazole (Pantpas(®)), given

2016 World journal of emergency medicine Controlled trial quality: predicted high

69. Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia Full Text available with Trip Pro

Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia Current studies have indicated a high ratio of psychological problems in functional dyspepsia (FD) which causes disturbance in its management, so recognition these problems help the process of treatment.This was a cross-sectional study with a sample size of 4763 carried out in Isfahan University of Medical Sciences in 2011. Modified ROME III questionnaire was used to evaluate FD

2016 Advanced biomedical research

70. Dyspepsia: When and How to Test for Helicobacter pylori Infection Full Text available with Trip Pro

criteria. In order to avoid invasive procedures and adverse effects, to minimize costs, to speed up diagnosis, and to provide the most appropriate treatments, primary care physicians need to recognize functional dyspepsia. Because symptoms do not reliably discriminate between organic and functional forms of the disease, anamnesis, family history of peptic ulcer and/or of gastric cancer, medication history, especially for nonsteroidal anti-inflammatory drugs, age, and physical examination could help (...) Dyspepsia: When and How to Test for Helicobacter pylori Infection Dyspepsia is defined as symptoms related to the upper gastrointestinal tract. Approximately 25% of western populations complain of dyspeptic symptoms each year. 70% of them do not have an organic cause and symptoms are related to the so-called functional dyspepsia, characterized by epigastric pain, early satiety, and/or fullness during or after a meal occurring at least weekly and for at least 6 months according to ROME III

2016 Gastroenterology research and practice

71. Treatment of Constipation in Functional Dyspepsia

Research Institute Study Details Study Description Go to Brief Summary: Background. Functional dyspepsia is characterized by symptoms that apparently originate in the stomach without detectable cause by conventional diagnosis test. The pathophysiology of functional dyspepsia is not known, but a number of data indicate that dyspeptic patients have increased sensitivity of the digestive system, so that physiological stimuli may induce their symptoms. Some patients with functional dyspepsia have also (...) : Treatment Official Title: Effect of Treatment of Constipation on Dyspeptic Symptoms in Patients With Constipation and Functional Dyspepsia Study Start Date : June 12, 2016 Actual Primary Completion Date : December 10, 2017 Actual Study Completion Date : January 8, 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Biofeedback for constipation Constipation will be treated by correcting functional outlet

2016 Clinical Trials

72. Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease

Information provided by (Responsible Party): Weifeng Wang, MD, Chinese PLA General Hospital Study Details Study Description Go to Brief Summary: Endoscopic Tri-Modal Imaging which combines Narrow-band Imaging(NBI), Autofluorescence Imaging (AFI) and White-light Imaging (WLI) could be used to identify the indistinct changes in the gut caused by reflux disease,either acid reflux or bile reflux, which make it possible to differentiate reflux disease from functional dyspepsia (FD). Condition or disease (...) Intervention/treatment Phase Gastroesophageal Reflux Disease Dyspepsia Bile Reflux Device: Endoscopic Tri-Modal Imaging Drug: Omeprazole Other: Analysis of gastric juice Not Applicable Detailed Description: Functional dyspepsia (FD) and acid/bile reflux disease are common. These diseases share similar clinical manifestations. Individuals with functional dyspepsia (FD) often present upper abdominal pain or discomfort, bloating, early satiety, loss of appetite, and no organic factors underlie it. Individuals

2016 Clinical Trials

73. Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia.

University WanFang Hospital. Recruitment status was: Recruiting First Posted : April 14, 2016 Last Update Posted : March 3, 2017 Sponsor: Taipei Medical University WanFang Hospital Information provided by (Responsible Party): Ming-Shun Wu, Taipei Medical University WanFang Hospital Study Details Study Description Go to Brief Summary: Patients with indigestion were often found in gastroenterology clinic, those who about 20 % was caused by organic, while the rest of patients are showed abnormal inspection (...) of medical service , also reduce health care cost and unequally medical information. Anxiety and depression are two common reactions when it comes to negative emotional states, which related to a body and caused a vicious cycle of disease. Some patients suffer from functional dyspepsia symptoms were diagnosed with anxiety or depression symptoms often ignore body care due to lack of health literacy. The purpose of this study is to investigate the distribution of functional dyspepsia patients with health

2016 Clinical Trials

74. Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia

Products Worldwide Information provided by (Responsible Party): Johnson & Johnson Consumer and Personal Products Worldwide Study Details Study Description Go to Brief Summary: The aim of this study is to show non-inferiority of two brands of simeticone in adult patients suffering from functional dyspepsia. Condition or disease Intervention/treatment Phase Functional Dyspepsia Drug: Imonogas Drug: Espumisan Phase 3 Detailed Description: This is a multi-center, randomized, observer-blind, parallel-group (...) -weeks Non-inferiority Clinical Trial to Compare the Efficacy and Safety of Two Brands of Simeticone for Symptomatic Treatment of Functional Dyspepsia in Adults Study Start Date : February 2016 Actual Primary Completion Date : October 2016 Actual Study Completion Date : December 2016 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Imonogas Imonogas 120 mg, 1 capsule three times daily for 8

2016 Clinical Trials

75. Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.

in their symptoms on the diet. This improvement could be explained by reduction in duodenal and gastric distention with the low FODMAP diet or a change in the duodenal flora. To date, there have been no randomized trials evaluating dietary modification in FD. The purpose of this study is to evaluate the efficacy of the low FODMAP diet in functional dyspepsia. The investigator's hypothesis is that the addition of the FODMAP diet to standard medical treatment will result in improved symptom control in patients (...) (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Men and women 18 years and older Diagnosis of FD with either PDS or EPS as measured by Rome III Criteria Patients describing inadequate relief of dyspepsia symptoms Endoscopy performed in the last 3 years and negative for an organic cause for dyspeptic symptoms H pylori negative by non-invasive testing or biopsy. Patients with a history of successfully eradicated H pylori will be included

2016 Clinical Trials

76. Functional dyspepsia. (Abstract)

Functional dyspepsia. Structural causes are absent in more than 50% of patients with symptoms referred to the gastroduodenal region when routine diagnostic tests are applied. New knowledge holds the prospect that targeted therapy may more optimally manage subsets of these patients with functional dyspepsia.An understanding of gut-to-brain and brain-to-gut pathways in functional dyspepsia is expanding. Minimal mucosal inflammation with eosinophils (and in some cases mast cells) characterized (...) by ultrastructural changes in the duodenum appears to be present in a substantial subgroup of functional dyspepsia patients as identified now by investigators globally. Although antibiotic therapy targeting Helicobacter pylori appears to be effective in a small proportion of functional dyspepsia patients, eradication therapy may be more effective in functional dyspepsia patients with microscopic duodenal inflammation, a potentially important finding needing to be confirmed. This may suggest that the effects

2015 Current opinion in gastroenterology

77. Efficacy and safety of Honey based formulation of nigella sativa seed oil in functional dyspepsia: A double blind randomized controlled clinical trial. (Abstract)

supplementation of honey based formulation of N. sativa can cause significant symptomatic improvement of patients with functional dyspepsia whom received the standard anti-secretory therapy. The results should be investigated further in studies with longer duration and larger sample size.Published by Elsevier Ireland Ltd. (...) Efficacy and safety of Honey based formulation of nigella sativa seed oil in functional dyspepsia: A double blind randomized controlled clinical trial. A honey based formulation from Nigella sativa L. (N. sativa) has been used in Traditional Persian Medicine for upper gastrointestinal symptoms. Considering the traditional use of this formulation and its ingredients known pharmacologic effects, this study aimed to evaluate the efficacy and safety of N. sativa seed oil mixed with honey

2015 Journal of Ethnopharmacology Controlled trial quality: predicted high

78. Effects of Diet on Reflux and Dyspepsia

drug within the 30 days preceding and during the present study (purely diagnostic studies are acceptable), individuals unwilling to provide written informed consent, inability to follow the procedures of the study, e.g. due to language problems (all study documents in English). Participants with a history of alcohol dependency or medical conditions that may be exacerbated or affected by alcohol intake are allowed to participate but are instructed not to drink the alcohol provided with the high (...) Effects of Diet on Reflux and Dyspepsia Effects of Diet on Reflux and Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effects of Diet on Reflux and Dyspepsia The safety and scientific validity

2015 Clinical Trials

79. A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

, 2018 Sponsor: Yuhan Corporation Information provided by (Responsible Party): Yuhan Corporation Study Details Study Description Go to Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled dose-finding phase 2 trial to evaluate the efficacy and safety of YH12852 in patients with functional dyspepsia. Condition or disease Intervention/treatment Phase Functional Dyspepsia Drug: YH12852 0.1 mg Drug: YH12852 0.25 mg Drug: YH12852 0.5 mg Drug: Placebo Phase 2 Detailed (...) ) Primary Purpose: Treatment Official Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Dose-finding Phase 2 Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia Study Start Date : October 2015 Estimated Primary Completion Date : January 2020 Estimated Study Completion Date : January 2020 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: YH12852 0.1 mg

2015 Clinical Trials

80. Effectiveness of tDCS for the Treatment of Functional Dyspepsia

information, Layout table for eligibility information Ages Eligible for Study: 18 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: functional dyspeptic patients according to Rome IV criteria clinical investigation reporting absence of organic causes of functional dyspepsia Exclusion Criteria history of brain trauma, haemorrhage or ischemia implantable devices such as pacemaker alcohol or drug abuse epilepsy severe chronic (...) Dornelles Information provided by (Responsible Party): Carine Leite, Hospital Ernesto Dornelles Study Details Study Description Go to Brief Summary: Functional dyspepsia is a very common disorder of great challenge to clinical management. A therapeutic targets is up-regulation of visceral pain threshold. The transcranial direct current stimulation (tDCS) is a novel therapy that pursues these properties, besides its safety and easy adherence. There is a great need of new treatments for functional

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>